Eli Lilly's R&D expenditure as a share of revenue 2010-2019

This statistic depicts the spending on research and development by Eli Lilly and Company, shown as a share of revenue from 2010 to 2019. In 2019, the company spent some 25 percent of its revenue for R&D purposes. Eli Lilly and Company is an international pharmaceutical company, headquartered in Indianapolis, Indiana.

Eli Lilly and Company's spending for research and development as a share of revenue from 2010 to 2019*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2010 to 2019

Supplementary notes

* All values have been calculated based on the company's selected financial data.
This statistic was assembled from several of Eli Lilly's annual reports.
** Includes the effects of the Elanco Animal Health spin-off. Previous years were not restated accordingly.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Eli Lilly"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.